Key result
Cardiac rehabilitation after PCI is linked to ~80% lower 12-month mortality versus non-attendance.
Why the study?
Cardiac rehabilitation is a key component of secondary prevention after PCI, yet participation remains suboptimal.
Does cardiac rehabilitation attendance improve 12-month mortality and reduce unplanned readmissions in adults following percutaneous coronary intervention?
Cohort (n=7,172)
Yes
Does cardiac rehabilitation attendance improve 12-month mortality and reduce unplanned readmissions in adults following percutaneous coronary intervention?
Absolute Event Rate: 1% vs 4.9%
p-value: p=<0.001
Cardiac rehabilitation attendance, particularly at higher session doses, is associated with significantly lower 12-month mortality and unplanned readmissions following percutaneous coronary intervention.
May support broader cardiac rehabilitation access; leaves open causal confirmation without randomization.
BACKGROUND: Cardiac rehabilitation is a key component of secondary prevention following percutaneous coronary intervention (PCI), yet participation remains suboptimal. Linked health datasets offer an opportunity to better understand attendance patterns and associated outcomes across the care continuum. METHODS: A retrospective, observational cohort study was conducted using linked health data from 13 public hospitals between 2019 and 2021. Cardiac rehabilitation attendance was defined as participation in ≥1 session. Predictors of cardiac rehabilitation attendance and 12-month outcomes were assessed. A dose-response analysis was also performed, categorizing participants by cardiac rehabilitation session frequency as non-attenders, low attendance (1-5 sessions) and high attendance (≥6 sessions). RESULTS: Adults undergoing PCI (n = 37,191) were identified, of whom 7126 were successfully linked to the Victorian Integrated Non-Admitted Health (VINAH) dataset. Cardiac rehabilitation attendance was observed in 19.3% of the cohort. Key predictors of attendance were STEMI (OR 1.59, 95% CI 1.32-1.93), NSTEMI (OR 1.24, 95% CI 1.05-1.46), rural/regional program location (OR 1.48, 95% CI 1.25-1.75), and length of stay >3 days (OR 1.04, 95% CI 1.02-1.07). At 12 months, cardiac rehabilitation attendees had lower mortality (1.0% vs 4.9%, p < 0.001) and fewer unplanned readmissions (p = 0.038). A dose-response relationship was found for 12-month mortality. A dose-response relationship was evident for mortality, with lowest rates among high-attendance participants (0.6%), compared with low-attendance (1.5%) and non-attenders (2.9%) (p < 0.001). CONCLUSIONS: Linking Victorian datasets is feasible and provides valuable insights. Cardiac rehabilitation attendance is low, yet participation, particularly at higher doses, is associated with significantly improved outcomes.
No takes yet. Share an insight, caveat, or question.
Cartledge et al. (2026) conducted a cohort in Percutaneous coronary intervention (PCI) (n=7,172). Cardiac rehabilitation attendance vs. Non-attendance was evaluated on 12-month mortality (p=<0.001). Cardiac rehabilitation attendance following PCI was associated with significantly lower 12-month mortality compared to non-attendance (1.0% vs 4.9%, p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: